Detalhe da pesquisa
1.
Vasoactive intestinal peptide reduces the inflammatory profile in mice infected with Trypanosoma cruzi.
Exp Parasitol
; 159: 72-8, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26358268
2.
Galectin-3 (Gal-3) and the tissue inhibitor of matrix metalloproteinase (TIMP-2) as potential biomarkers for the clinical evolution of chronic Chagas cardiomyopathy.
Acta Trop
; 252: 107153, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38373528
3.
Galectin-3 and fibrosis intensity in Chronic Chagas Cardiomyopathy: a systematic review.
Rev Inst Med Trop Sao Paulo
; 64: e45, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35749417
4.
Reduced vitamin D receptor (VDR) and cathelicidin antimicrobial peptide (CAMP) gene expression contribute to the maintenance of inflammatory immune response in leprosy patients.
Microbes Infect
; 24(6-7): 104981, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35462022
5.
Vasoactive intestinal peptide degradation might influence Interleukin-17 expression in cardiac chagasic patients.
Rev Inst Med Trop Sao Paulo
; 60: e57, 2018 Oct 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-30365640
6.
Galectin-3 and fibrosis intensity in Chronic Chagas Cardiomyopathy: a systematic review
Rev. Inst. Med. Trop. São Paulo (Online)
; 64: e45, 2022. tab, graf
Artigo
em Inglês
|
LILACS-Express
| ID: biblio-1387337